A review of portal vein embolization prior to hepatic resection.
future liver remnant
liver resection
portal vein embolization
posthepatectomy liver failure
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
revised:
13
05
2024
received:
06
02
2024
accepted:
09
06
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
15
10
2024
Statut:
ppublish
Résumé
Primary and metastatic liver cancers are increasing in incidence, and the approaches with the longest survival are resection and transplantation. Posthepatectomy liver failure (PHLF) is the leading cause of mortality following liver resection. PHLF is largely due to liver insufficiency due to the insufficient size of the future liver remnant (FLR). In this review, we will describe portal vein embolization, which is a neoadjuvant therapy used to induce hypertrophy in the FLR before resection.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
435-442Subventions
Organisme : None
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. Global trends in incidence rates of primary adult liver cancers: a systematic review and meta‐analysis. Front Oncol. 2020;10:171. doi:10.3389/fonc.2020.00171
Wu KT. Hepatocellular carcinoma: clinical study of long‐term survival and choice of treatment modalities. World J Gastroenterol. 2013;19(23):3649‐3657. doi:10.3748/wjg.v19.i23.3649
Wang P. Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials. World J Gastroenterol. 2005;11(25):3817‐3822. www.wjgnet.com
Rahnemai‐Azar AA, Cloyd JM, Weber SM, et al. Update on liver failure following hepatic resection: strategies for prediction and avoidance of post‐operative liver insufficiency. J Clin Transl Hepatol. 2018;6(1):1‐8. doi:10.14218/JCTH.2017.00060
Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107(5):521‐527.
Kiseleva Yv, Antonyan SZ, Zharikova TS, Tupikin KA, Kalinin Dv, Zharikov YO. Molecular pathways of liver regeneration: a comprehensive review. World J Hepatol. 2021;13(3):270‐290. doi:10.4254/wjh.v13.i3.270
Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286‐300. doi:10.1002/jcp.21172
Min JS, DeAngelis RA, Reis ES, et al. Systems analysis of the complement‐induced priming phase of liver regeneration. J Immunol. 2016;197(6):2500‐2508. doi:10.4049/jimmunol.1600628
Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology. 2009;137(2):466‐481. doi:10.1053/j.gastro.2009.05.044
Gilgenkrantz H, Collin de l'Hortet A. Understanding liver regeneration. Am J Pathol. 2018;188(6):1316‐1327. doi:10.1016/j.ajpath.2018.03.008
Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer long‐term results. Ann Surg. 2000;231:487‐499.
Yadav K, Shrikhande S, Goel M. Post hepatectomy liver failure: concept of management. J Gastroint Cancer. 2014;45:405‐413. doi:10.1007/s12029-014-9646-3
Heymsfield SB. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90(2):185‐187. doi:10.7326/0003-4819-90-2-185
Lamade W. The impact of 3‐dimensional reconstructions on operation planning in liver surgery. Arch Surg. 2000;135(11):1256‐1261. doi:10.1001/archsurg.135.11.1256
de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM. Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg. 2011;98(6):825‐834. doi:10.1002/bjs.7456
Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188(3):304‐309. doi:10.1016/s1072-7515(98)00301-9
Vauthey J. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8(3):233‐240. doi:10.1053/jlts.2002.31654
Johnson TN, Tucker GT, Tanner MS, Rostami‐Hodjegan A. Changes in liver volume from birth to adulthood: a meta‐analysis. Liver Transpl. 2005;11(12):1481‐1493. doi:10.1002/lt.20519
Olthof PB, van Dam R, Jovine E, et al. Accuracy of estimated total liver volume formulas before liver resection. Surgery. 2019;166(3):247‐253. doi:10.1016/j.surg.2019.05.003
DeLand FH, North WA. Relationship between liver size and body size. Radiology. 1968;91(6):1195‐1198. doi:10.1148/91.6.1195
Heinemann A, Wischhusen F, Püschel K, Rogiers X. Standard liver volume in the Caucasian population. Liver Transpl Surg. 1999;5(5):366‐368. doi:10.1002/lt.500050516
Shindoh J, Tzeng CWD, Aloia TA, et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013;20(8):2493‐2500. doi:10.1245/s10434-012-2864-7
Schwarz C, Plass I, Fitschek F, et al. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Sci Rep. 2019;9:8421. doi:10.1038/s41598-019-44815-x
Collin Y, Paré A, Belblidia A, et al. Portal vein embolization does not affect the long‐term survival and risk of cancer recurrence among colorectal liver metastases patients: a prospective cohort study. Int J Surg. 2019;61:42‐47. doi:10.1016/j.ijsu.2018.11.029
May B, Madoff D. Portal vein embolization: rationale, technique, and current application. Semin Intervent Radiol. 2012;29:081‐089. doi:10.1055/s-0032-1312568
Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff D. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol. 2008;25(2):132‐145. doi:10.1055/s-2008-1076686
Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188(3):304‐309. doi:10.1016/s1072-7515(98)00301-9
Orcutt ST, Kobayashi K, Sultenfuss M, et al. Portal vein embolization as an oncosurgical strategy prior to major hepatic resection: anatomic, surgical, and technical considerations. Front Surg. 2016;3:1. doi:10.3389/fsurg.2016.00014
Shimura T, Suehiro T, Suzuki H, Okada K, Araki K, Kuwano H. Trans‐ileocecal portal vein embolization as a preoperative treatment for right trisegmentectomy with caudate lobectomy. J Surg Oncol. 2007;96(5):438‐441. doi:10.1002/jso.20829
Kodama Y, Shimizu T, Endo H, Miyamoto N, Miyasaka K. Complications of percutaneous transhepatic portal vein embolization. J Vasc Interv Radiol. 2002;13(12):1233‐1237. doi:10.1016/s1051-0443(07)61970-8
di Stefano DR, de Baere T, Denys A, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology. 2005;234(2):625‐630. doi:10.1148/radiol.2342031996
Orcutt ST, Kobayashi K, Sultenfuss M, et al. Portal vein embolization as an oncosurgical strategy prior to major hepatic resection: anatomic, surgical, and technical considerations. Front Surg. 2016;3:14. doi:10.3389/fsurg.2016.00014
Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111(4):1018‐1022. doi:10.1016/s0016-5085(96)70070-7
Huang SY, Aloia TA. Portal vein embolization: state‐of‐the‐art technique and options to improve liver hypertrophy. Visc Med. 2017;33(6):419‐425. doi:10.1159/000480034
van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36(1):25‐34. doi:10.1007/s00270-012-0440-y
Comby PO, Guillen K, Chevallier O, et al. Endovascular use of cyanoacrylate‐lipiodol mixture for peripheral embolization: properties, techniques, pitfalls, and applications. J Clin Med. 2021;10(19):4320. doi:10.3390/jcm10194320
Luz JHM, Veloso Gomes F, Costa NV, et al. BestFLR trial: liver regeneration at CT before major hepatectomies for liver cancer—a randomized controlled trial comparing portal vein embolization with N‐butyl‐cyanoacrylate plus iodized oil versus polyvinyl alcohol particles plus coils. Radiology. 2021;299(3):715‐724. doi:10.1148/radiol.2021204055
Ali A, Ahle M, Björnsson B, Sandström P. Portal vein embolization with N‐butyl cyanoacrylate glue is superior to other materials: a systematic review and meta‐analysis. Eur Radiol. 2021;31(8):5464‐5478. doi:10.1007/s00330-020-07685-w
Ali A, Ahle M, Björnsson B, Sandström P, Ali Adnanali A. Portal vein embolization with N‐butyl cyanoacrylate glue is superior to other materials: a systematic review and meta‐analysis. Eur Radiol. 2021;31(8):5464‐5478. doi:10.1007/s00330-020-07685-w/Published
Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099‐1105.
Santhakumar C, Ormiston W, McCall JL, Bartlett A, Duncan D, Holden A. Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant. CVIR Endovasc. 2022;5(1):36. doi:10.1186/s42155-022-00312-3
Fischman AM, Ward TJ, Horn JC, et al. Portal vein embolization before right hepatectomy or extended right hepatectomy using sodium tetradecyl sulfate foam: technique and initial results. J Vasc Interv Radiol. 2014;25(7):1045‐1053. doi:10.1016/j.jvir.2014.01.034
Camelo R, Luz JH, Gomes FV, Coimbra E, Costa NV, Bilhim T. Portal vein embolization with PVA and coils before major hepatectomy: single‐center retrospective analysis in sixty‐four patients. J Oncol. 2019;2019:1‐9. doi:10.1155/2019/4634309
Zhang CW, Dou CW, Zhang XL, et al. Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy. World J Gastroenterol. 2020;26(30):4489‐4500. doi:10.3748/wjg.v26.i30.4489
de Graaf W, van den Esschert JW, van Lienden KP, van Gulik TM. Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol. 2009;16(2):423‐430. doi:10.1245/s10434-008-0222-6
Hayashi S, Baba Y, Ueno K, et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol. 2007;48(7):721‐727. doi:10.1080/02841850701424514
Hoekstra LT, van Lienden KP, Doets A, Busch ORC, Gouma DJ, van Gulik TM. Tumor progression after preoperative portal vein embolization. Ann Surg. 2012;256(5):812‐818. doi:10.1097/SLA.0b013e3182733f09
Imamura H, Seyama Y, Makuuchi M, Kokudo N. Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the University of Tokyo experience. Semin Intervent Radiol. 2008;25(2):146‐154. doi:10.1055/s-2008-1076683
Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32‐41. doi:10.1016/j.ejso.2016.05.026
Yoo H, Kim JH, Ko GY, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol. 2011;18(5):1251‐1257. doi:10.1245/s10434-010-1423-3
Park GC, Lee SG, Yoon YI, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma. Hepatobili Pancr Dis Int. 2020;19(3):244‐251. doi:10.1016/j.hbpd.2020.04.008
Terasawa M, Allard MA, Golse N, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: an intent‐to‐treat analysis. Surgery. 2020;167(2):425‐431. doi:10.1016/j.surg.2019.09.023
Yoo H, Kim JH, Ko GY, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol. 2011;18(5):1251‐1257. doi:10.1245/s10434-010-1423-3
Nagino M, Kanai M, Morioka A, et al. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol. 2000;11(8):1063‐1068. doi:10.1016/S1051-0443(07)61340-2
Charles J, Nezami N, Loya M, et al. Portal vein embolization: rationale, techniques, and outcomes to maximize remnant liver hypertrophy with a focus on contemporary strategies. Life. 2023;13(2):279. doi:10.3390/life13020279
Teo JY, Allen JC, Ng DC, et al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. HPB. 2016;18(1):7‐12. doi:10.1016/j.hpb.2015.07.002
Bennink RJ, Cieslak KP, van Delden OM, et al. Monitoring of total and regional liver function after SIRT. Front Oncol. 2014;4:152. doi:10.3389/fonc.2014.00152
Bekki Y, Marti J, Toshima T, et al. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium‐90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. Surgery. 2021;169(5):1044‐1051. doi:10.1016/j.surg.2020.12.012
Bennink RJ, Cieslak KP, van Delden OM, et al. Monitoring of total and regional liver function after SIRT. Front Oncol. 2014;4:152. doi:10.3389/fonc.2014.00152
Salem R, Padia SA, Lam M, et al. Clinical, dosimetric, and reporting considerations for Y‐90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2023;50(2):328‐343. doi:10.1007/s00259-022-05956-w
Chiesa C, Sjogreen‐Gleisner K, Walrand S, et al. EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc‐MAA pre‐ and 90Y peri‐therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys. 2021;8(1):77. doi:10.1186/s40658-021-00394-3
Ho S, Lau WY, Leung TWT, et al. Partition model for estimating radiation doses from yttrium‐90 microspheres in treating hepatic tumours. Eur J Nucl Med. 1996;23(8):947‐952. doi:10.1007/BF01084369
Bolch WE, Bouchet LG, Robertson JS, et al. MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions—radionuclide S values at the voxel level. J Nucl Med. 1999;40(1):11.
Chen G, Lu Z, Jiang H, Lin KH, Mok GSP. Voxel‐S‐value based 3D treatment planning methods for Y‐90 microspheres radioembolization based on Tc‐99m‐macroaggregated albumin SPECT/CT. Sci Rep. 2023;13(1):4020. doi:10.1038/s41598-023-30824-4
Cassese G, Han HS, Lee B, et al. Portal vein embolization failure: current strategies and future perspectives to improve liver hypertrophy before major oncological liver resection. World J Gastrointest Oncol. 2022;14(11):2088‐2096. doi:10.4251/wjgo.v14.i11.2088
Kobayashi K, Yamaguchi T, Denys A, et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surgery. 2020;167(6):917‐923. doi:10.1016/j.surg.2019.12.006
Guiu B, Quenet F, Panaro F, et al. Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes. Hepatobiliary Surg Nutr. 2020;9(5):564‐576. doi:10.21037/hbsn.2020.02.06
Le Roy B, Gallon A, Cauchy F, et al. Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection. HPB. 2020;22(2):298‐305. doi:10.1016/j.hpb.2019.08.005
Laurent C, Fernandez B, Marichez A, et al. Radiological simultaneous portohepatic vein embolization (RASPE) before major hepatectomy: a better way to optimize liver hypertrophy compared to portal vein embolization. Ann Surg. 2020;272(2):199‐205. doi:10.1097/SLA.0000000000003905
Panaro F, Giannone F, Riviere B, et al. Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr. 2019;8(4):329‐337. doi:10.21037/hbsn.2019.07.06
Guiu B, Herrero A, Panaro F. Liver venous deprivation: a bright future for liver metastases—but what about hepatocellular carcinoma? Hepatobiliary Surg Nutr. 2021;10(2):270‐272. doi:10.21037/hbsn-21-7
Chaouch MA, Mazzotta A, da Costa AC, et al. A systematic review and meta‐analysis of liver venous deprivation versus portal vein embolization before hepatectomy: future liver volume, postoperative outcomes, and oncological safety. Front Med. 2024;10:1334661. doi:10.3389/fmed.2023.1334661
Khayat S, Cassese G, Quenet F, et al. Oncological outcomes after liver venous deprivation for colorectal liver metastases: a single center experience. Cancers. 2021;13(2):200. doi:10.3390/cancers13020200
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2‐staged extended right hepatic resection in small‐for‐size settings. Ann Surg. 2012;255(3):405‐414. doi:10.1097/SLA.0b013e31824856f5
Kim D, Cornman‐Homonoff J, Madoff DC. Preparing for liver surgery with “alphabet soup”: PVE, ALPPS, TAE‐PVE, LVD and RL. Hepatobiliary Surg Nutr. 2020;9(2):136‐151. doi:10.21037/hbsn.2019.09.10
Liu Y, Yang Y, Gu S, Tang K. A systematic review and meta‐analysis of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus traditional staged hepatectomy. Medicine. 2019;98(15):e15229. doi:10.1097/MD.0000000000015229
Michal K, Sau M, Tamara GMH, Long JR. A better route to ALPPS: minimally invasive vs open ALPPS. Surg Endosc. 2020;34(6):2379‐2389. doi:10.1007/s00464-020-07437-3
Schadde E, Ardiles V, Robles‐Campos R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg. 2014;260(5):829‐838.
discussion: 836‐838. doi:10.1097/SLA.0000000000000947
Kang D, Schadde E. Hypertrophy and liver function in ALPPS: correlation with morbidity and mortality. Visc Med. 2017;33(6):426‐433. doi:10.1159/000479477
Wanis KN, Linecker M, Madenci AL, et al. Variation in complications and mortality following ALPPS at early‐adopting centers. HPB. 2021;23(1):46‐55. doi:10.1016/j.hpb.2020.04.009
Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43(1):32‐41. doi:10.1016/j.ejso.2016.05.026
Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232(5):665‐672. doi:10.1097/00000658-200011000-00008
Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta‐analysis. Ann Surg. 2008;247(1):49‐57. doi:10.1097/SLA.0b013e31815f6e5b
Yeom YK, Shin JH. Complications of portal vein embolization: evaluation on cross‐sectional imaging. Korean J Radiol. 2015;16(5):1079‐1085. doi:10.3348/kjr.2015.16.5.1079
Ganeshan DM, Szklaruk J. Portal vein embolization: cross‐sectional imaging of normal features and complications. Am J Roentgenol. 2012;199(6):1275‐1282. doi:10.2214/AJR.12.8636
Shaw C, Madoff D. Acute thrombosis of left portal vein during right portal vein embolization extended to segment 4. Semin Intervent Radiol. 2011;28:156‐161. doi:10.1055/s-0031-1280655
Bilbao J, Martínez‐Cuesta A, Urtasun F, Cosín O. Complications of embolization. Semin Intervent Radiol. 2006;23(2):126‐142. doi:10.1055/s-2006-941443
Liao Y, Cai Q, Zhang X, Li F. Sequential transcatheter arterial chemoembolization and portal vein embolization before hepatectomy for the management of patients with hepatocellular carcinoma: a systematic review and meta‐analysis. Updates Surg. 2023;75(7):1741‐1750. doi:10.1007/s13304-023-01571-y
Bell RJ, Hakeem AR, Pandanaboyana S, Davidson BR, Prasad RK, Dasari BVM. Portal vein embolization versus dual vein embolization for management of the future liver remnant in patients undergoing major hepatectomy: meta‐analysis. BJS Open. 2022;6(6):zrac131. doi:10.1093/bjsopen/zrac131
Heil J, Korenblik R, Heid F, et al. Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis. Br J Surg. 2021;108(7):834‐842. doi:10.1093/bjs/znaa149
Tustumi F, Ernani L, Coelho FF, et al. Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta‐analysis. HPB. 2018;20(12):1109‐1118. doi:10.1016/j.hpb.2018.06.1798
Yamashita S, Sakamoto Y, Yamamoto S, et al. Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single‐center experience of 319 cases. Ann Surg Oncol. 2017;24(6):1557‐1568. doi:10.1245/s10434-017-5800-z
Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol. 2012;57(3):692‐694. doi:10.1016/j.jhep.2012.04.016
Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39(6):1477‐1487. doi:10.1002/hep.20214
Esch JS, Schmelzle M, Fürst G, et al. Infusion of CD133+ bone marrow‐derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single‐center study. Ann Surg. 2012;255(1):79‐85. doi:10.1097/SLA.0b013e31823d7d08
Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long‐term results. Ann Surg. 2000;231(4):487‐499. doi:10.1097/00000658-200004000-00006
Ludvík J, Duras P, Třeška V, et al. Portal vein embolization with contralateral application of stem cells facilitates increase of future liver remnant volume in patients with liver metastases. Cardiovasc Intervent Radiol. 2017;40(5):690‐696. doi:10.1007/s00270-017-1566-8